Percent decline in North American cardiac surgical operative volume during the COVID-19 pandemic Central MessageThe COVID-19 pandemic has resulted in a decline to 45% of baseline in cardiac surgery case volumes as institutions defer nonurgent operations, with changes in case mix. PerspectiveWe describe the experience of 67 North American adult cardiac surgery institutional experience and demonstrate national and regional variations in response to COVID-19. These findings provide valuable information regarding the volume of patients with procedures deferred to help predict and prepare for the post--COVID-19 surge in cardiac surgery demand. See Commentary on page XXX.

The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on health care, leading to marked global morbidity and mortality.[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8] Cardiac surgery is a resource-intensive procedure in regards to intensive care resources.[@bib3] In the efforts to preserve and redirect limited resources and personnel for the treatment of patients with COVID-19,[@bib9] nonurgent cardiac surgical services have been deferred per national and regional policies as well as recommendations from the American College of Surgeons and Society of Thoracic Surgeons COVID-19 Taskforce.[@bib1] Patients with cardiovascular disease, in particular, those with pathology warranting surgical intervention, are often unstable at presentation to the hospital or may become very symptomatic while waiting for their procedure. Therefore, during the pandemic, most operated patients required urgent intervention.[@bib10] Furthermore, it is anticipated that there may be progressive increase in deferred cases during the pandemic that will require completion within a limited time frame once restrictions ease.[@bib11]

The effect of COVID-19 on North American cardiac surgical volumes, resource management, and outcomes remains unclear. Understanding the impact of COVID-19 on cardiac surgical volumes and the potential regional and institutional differences in crisis management may provide guidance on postpandemic hospital operating capacity required to treat deferred cases.[@bib8] ^,^ [@bib11], [@bib12], [@bib13] In addition, information on the extent of deferred patients can help institutions proactively prepare to reduce the risk of increased morbidity and mortality for patients waiting for procedures.[@bib3] The present study aims to report the collective North American adult cardiac surgical experience with COVID-19 through the evaluation of changes in cardiac surgical case volume, case mix, and outcomes, as stratified by hospitals with high and low burden of hospitalized patients with COVID-19.

Methods {#sec1}
=======

Study Design {#sec1.1}
------------

A web-based survey using the Qualtrics Survey Software (Qualtrics, Provo, Utah) was sent to a representative cardiac surgeon from each major North American adult cardiac surgical center to recruit participating centers ([Table E1](#tblE1){ref-type="table"}). The survey was face validated by 2 independent surgeons and sent on April 17, 2020, with discontinuation of survey link access on May 2, 2020. The response rate was 40% (67/167), representing cardiac surgery annualized case volumes of 60,452 in 2019. The survey tool consisted of multiple-choice and text entry items and was developed by the principal investigators (N.A., J.L., T.N.) with several iterations of internal review and revision, and finally, external feedback solicited from several board-certified actively practicing cardiac surgeons. The survey evaluated institutional annual and monthly cardiac surgical case volume, case mix, COVID-19 cardiac surgical volume and outcomes, hospital capacity, and methods institutions used to optimize COVID-19 surge capacity. The study was approved by the Adventist Health Care institutional review board (protocol no. 2020-09).

Definitions {#sec1.2}
-----------

Patients confirmed as having COVID-19 were defined as those who received a positive result on their nasopharyngeal swab or any other additional test (eg, endotracheal tube aspirate), whereas those who were classified as suspected as having COVID-19 or persons under investigations were defined as those who were symptomatic or had previous COVID-19 exposure and were awaiting a confirmatory COVID-19 test. Institutions with high burden of COVID-19 were defined as those with ≥100 hospitalized patients with confirmed or suspected COVID-19. Institutions with a low burden of COVID-19 were defined as those with \<100 hospitalized patients with confirmed or suspected COVID-19. Pre-COVID-19 was defined as before March 1, 2020, with during COVID-19 defined as March 1, 2020, onwards.

Statistical Analyses {#sec1.3}
--------------------

Parametric continuous variables are expressed as mean ± standard deviation and were compared by the use of the Student *t* test. Nonparametric continuous variables are expressed as medians (interquartile range) and were compared by the use of the Mann--Whitney *U* test. Categorical data were expressed as counts and percentages, and the χ^2^ test was used to analyze differences between groups. Statistical analyses were performed using Stata (Stata Corp, College Station, Tex) with significance at an alpha level of 0.05.

Results {#sec2}
=======

Demographics {#sec2.1}
------------

Our study comprises 67 adult cardiac surgery institutions, representing 60,452 cardiac surgical operations per year for 2019 with a combined capacity at baseline of 45,417 hospital beds, 6692 intensive care beds, 2664 operating rooms, and a total of 14,640 hospitalized patients with confirmed or suspected COVID-19. Institution geographic distribution and burden of hospitalized patients with confirmed or suspected COVID-19 are shown in [Figure 1](#fig1){ref-type="fig"} , with 22 (33%) institutions categorized as having a high and 45 (67%) with a low burden of hospitalized patients with COVID-19. Institution characteristics stratified by geographic region are shown in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} . Academic centers comprised the majority (n = 53, 79%), with institutions with a high burden of COVID-19 more likely to be academic centers (high burden 91% vs low burden 48%, *P* = .003) and to be larger institutions in terms of hospital beds (high burden 916 vs low burden 561, *P* = .009), intensive care unit beds (high burden 163 vs low burden 69, *P* = .003), and operating room capacity (high burden 55 vs low burden 32, *P* = .043) ([Table 3](#tbl3){ref-type="table"} ). All institutions reported to have curtailed nonurgent cardiac surgical operations, with the majority having instituted these policies between March 15 and 31, 2020 (n = 48, 72%), followed by March 1 to 14, 2020 (n = 15, 22%) and the remaining April 1, 2020, onwards (n = 4, 6%) ([Table 2](#tbl2){ref-type="table"}).Figure 1A, Geographic distribution of institutions; B, proportion of total hospitalized patients with COVID-19 of institutions for each region; and C, proportion of hospitalized patients with COVID-19 to total number of hospital beds for each region. *COVID-19*, Coronavirus disease 2019.Table 1Institutional pre- and during COVID characteristicsUnited StatesCanadaAll (n = 67)Northeast (n = 15)Southeast (n = 12)Southwest (n = 7)Midwest (n = 7)West (n = 9)Eastern (n = 9)Western (n = 8)Institution characteristics, n Annual pump volume959.3 ± 449.5632.2 ± 323.0700.3 ± 467.51258.7 ± 1007.6567.6 ± 453.71216.8 ± 529.51088.1 ± 498.2902.3 ± 567.8 Hospital beds697.7 ± 341.9728.8 ± 240.51119.3 ± 1293.3772.0 ± 574.3511.1 ± 259.2406.7 ± 201.4588.3 ± 329.8677.9 ± 527.3 ICU beds105.0 ± 70.9113.6 ± 67.9228.4 ± 339.294.4 ± 64.177.3 ± 58.852.0 ± 25.141.3 ± 21.499.9 ± 125.7 Operating rooms39.5 ± 19.632.3 ± 11.099.6 ± 105.655.4 ± 47.932.7 ± 19.021.0 ± 14.014.5 ± 7.039.8 ± 44.1 COVID-19--confirmed patients929.6 ± 422.3118.6 ± 70.3190.6 ± 363.194.1 ± 57.435.1 ± 42.524.8 ± 30.213.8 ± 15.2146.6 ± 472.2 COVID-19--suspected patients29.4 ± 32.146.8 ± 96.9425.0 ± 929.969.6 ± 95.016.1 ± 14.320.7 ± 20.63.1 ± 5.671.9 ± 310.5Case distribution pre--COVID-19, % Valve26.6 ± 9.731.7 ± 14.922.4 ± 9.626.6 ± 13.425.2 ± 10.527.9 ± 7.922.9 ± 5.326.6 ± 10.7 Valve + CABG12.6 ± 6.210.3 ± 5.710.0 ± 4.110.2 ± 3.916.2 ± 7.410.3 ± 4.713.6 ± 6.112.0 ± 5.8 CABG40.3 ± 19.037.8 ± 23.940.0 ± 25.433.6 ± 14.338.1 ± 20.247.8 ± 10.945.5 ± 11.440.5 ± 18.5 Aortic surgery12.1 ± 9.010.5 ± 7.814.4 ± 12.813.0 ± 6.316.8 ± 11.29.9 ± 4.99.2 ± 5.512.1 ± 8.5 ECMO/MCS3.6 ± 4.12.8 ± 3.34.4 ± 5.36.8 ± 6.42.0 ± 3.51.6 ± 1.92.8 ± 2.43.3 ± 4.0 Heart transplant1.2 ± 1.94.3 ± 7.32.6 ± 2.12.3 ± 2.81.7 ± 3.51.2 ± 1.81.1 ± 2.22.1 ± 3.8 Other1.2 ± 1.94.3 ± 7.32.6 ± 2.12.3 ± 2.81.7 ± 3.51.2 ± 1.81.1 ± 2.22.1 ± 3.8Case distribution during COVID-19, % Valve22.0 ± 18.725.5 ± 17.318.1 ± 11.221.8 ± 13.920.6 ± 17.928.0 ± 11.520.8 ± 8.622.7 ± 14.9 Valve + CABG6.4 ± 6.17.7 ± 6.03.6 ± 4.26.3 ± 9.79.1 ± 9.710.3 ± 7.415.3 ± 12.88.3 ± 8.4 CABG42.0 ± 27.342.8 ± 28.338.6 ± 33.047.0 ± 23.452.2 ± 33.553.9 ± 13.951.4 ± 21.346.5 ± 26.0 Aortic surgery11.8 ± 14.78.3 ± 7.118.0 ± 19.710.4 ± 5.113.9 ± 25.74.9 ± 5.07.4 ± 6.010.46 ± 14.0 ECMO/MCS5.4 ± 6.75.8 ± 7.814.7 ± 19.310.2 ± 7.50.9 ± 1.82.6 ± 3.51.0 ± 1.55.3 ± 8.9 Heart transplant4.0 ± 8.17.9 ± 12.11.9 ± 3.33.8 ± 6.02.2 ± 6.70.3 ± 1.00.8 ± 1.83.3 ± 7.4 Other8.4 ± 26.52.1 ± 5.85.1 ± 8.60.5 ± 1.21.1 ± 3.30.0 ± 0.03.5 ± 8.73.4 ± 13.2[^1]Table 2Institutional responses to COVID-19United StatesCanadaAll (n = 67)Northeast (n = 15)Southeast (n = 12)Southwest (n = 7)Midwest (n = 7)West (n = 9)Eastern (n = 9)Western (n = 8)Dates institutions halted elective cases, n (%) March 1-14, 20204 (27)3 (25)1 (14)0 (0)5 (56)0 (0)2 (25)15 (22) March 15-31, 202011 (73)9 (75)5 (72)6 (86)3 (33)8 (89)6 (75)48 (72) April 1, 2020 onwards0 (0)0 (0)1 (14)1 (14)1 (11)1 (11)0 (0)4 (6)Required conversion of the following locations to treating areas for patients with COVID-19, n (%) None0 (0)4 (33)1 (14)2 (29)3 (33)1 (11)2 (25)13 (19) CSICU9 (60)2 (17)0 (0)0 (0)2 (22)5 (56)1 (13)19 (28) Operating room6 (40)1 (8)0 (0)0 (0)0 (0)1 (11)2 (25)10 (15) Surgical wards12 (80)2 (17)2 (29)4 (57)0 (0)3 (33)0 (0)23 (34) Medical wards14 (93)6 (50)5 (71)5 (71)5 (56)7 (78)5 (63)47 (70) Convention centers/public facilities5 (33)2 (17)0 (0)1 (14)1 (11)3 (33)2 (25)14 (21) Ground construction of tents/buildings4 (27)3 (25)0 (0)1 (14)1 (11)0 (0)0 (0)9 (13) CCU1 (7)0 (0)1 (14)0 (0)1 (11)0 (0)2 (25)5 (7)Redeployed the following members of cardiac surgical teams, n (%) Cardiac surgeon9 (60)2 (17)2 (29)1 (14)2 (22)1 (11)0 (0)17 (25) Trainees12 (80)1 (8)3 (43)0 (0)1 (11)1 (11)1 (13)19 (28)Routinely screen with COVID-19 test the following individuals for COVID-19 before cardiac surgery, n (%) All cardiac surgery patients12 (80)7 (58)4 (57)6 (86)5 (56)3 (33)3 (38)40 (60) All emergency cardiac surgical patients8 (53)7 (58)2 (29)1 (14)3 (33)4 (44)2 (25)27 (40) Family members of cardiac surgical patients1 (7)0 (0)0 (0)0 (0)0 (0)1 (11)0 (0)2 (3)Mechanism exists for patients on waiting list to seek care without going to ED, n (%) Yes (total)9 (60)10 (83)6 (86)7 (100)8 (89)7 (78)8 (100)55 (82) Of those with follow-up As needed8 (89)8 (80)6 (100)6 (86)8 (100)5 (71)6 (75)47 (85) Reach out weekly/biweekly1 (11)2 (20)0 (0)1 (14)0 (0)2 (29)2 (25)8 (15)Use of telemedicine during COVID-19, n (%)11 (73)12 (100)7 (100)7 (100)9 (100)7 (78)8 (100)61 (91)[^2]Table 3Institutional characteristics and responses to COVID-19, stratified by high COVID-19 versus low COVID-19 hospitalization burdenHigh burden (n = 22)Low burden (n = 45)*P* valueInstitution characteristics, n Annual pump volume984.4 ± 414.6823.7 ± 650.1.294 Hospital beds916.4 ± 746.6561.2 ± 329.6.009 ICU beds163.0 ± 196.669.0 ± 48.0.003 Operating rooms55.3 ± 36.732.2 ± 45.7.043 COVID-19--confirmed patients400.0 ± 774.422.7 ± 20.5.002 COVID-19--suspected patients192.0 ± 529.113.2 ± 15.3.026Change in case-distribution (during to pre-COVID-19), % Valve−7.6 ± 20.7−2.6 ± 11.1.195 Valve + CABG−3.9 ± 8.1−3.6 ± 8.1.855 CABG7.2 ± 23.04.2 ± 16.6.550 Aortic surgery−3.5 ± 9.9−1.0 ± 9.5.328 ECMO/MCS2.5 ± 4.20.4 ± 4.4.678 Heart transplant2.7 ± 6.30.4 ± 4.4.090 Other2.6 ± 20.2−1.4 ± 5.3.206Dates institutions halted elective cases, n (%).890 March 1-14, 20206 (27)10 (22) March 15-31, 202016 (73)33 (73) April 1, 2020 onwards02 (4)Required conversion of the following locations to treating areas for patients with COVID-19, n (%).020 None0 (0)14 (31) CSICU10 (45)9 (20) Operating room6 (27)3 (7) Surgical wards15 (68)8 (18) Medical wards21 (95)26 (58) Convention centers/public facilities6 (27)8 (18) Ground construction of tents/buildings6 (27)3 (7) CCU4 (18)3 (7)Redeployed the following members of cardiac surgical teams, n (%).001 Cardiac surgeon13 (59)4 (9) Trainee15 (68)4 (9)Routinely screen with COVID-19 test the following individuals for COVID-19 before cardiac surgery, n (%).907 All cardiac surgery patients17 (77)23 (51) All emergency cardiac surgical patients9 (41)18 (40) Family members of cardiac surgical patients0 (0)2 (4)Mechanism exists for patients on waiting list to seek care without going to ED, n (%) Yes (Total)17 (77)38 (84).798 Of those with follow-up.988 As needed15 (88)33 (87) Reach out weekly/biweekly2 (12)5 (13)Use of telemedicine during COVID-19, n (%)17 (77)44 (98).012[^3]

Hospital Resources and Strain of COVID-19 on Health Care System {#sec2.2}
---------------------------------------------------------------

The majority of centers have converted medical wards to COVID-19--treating areas (70%), followed by surgical wards (34%), cardiac surgical intensive care units (28%), convention centers or public facilities (21%), operating rooms (15%), ground-up construction with tents or buildings (13%), and cardiovascular care units (7%). Overall, a minority of cardiac surgeons (25%) and trainees (28%) required redeployment to alternative duties ([Table 2](#tbl2){ref-type="table"}). [Table 2](#tbl2){ref-type="table"} demonstrates the regional variation in increased conversion of alternative locations to COVID-19--treating facilities and redeployment of surgeons and trainees, with the greatest proportion of institutions located in the Northeast region of the United States, which also has the greatest burden of COVID-19. When stratified by burden of hospitalized patients with COVID-19, institutions with high burden were more likely to require conversion of alternative locations to COVID-19--treating areas (*P* = .020) and redeployment of surgeons (high burden 59% vs low burden 9%, *P* = .001) and trainees (high burden 68% vs low burden 9%, *P* = .001) to alternative duties ([Table 3](#tbl3){ref-type="table"}).

Effect of COVID-19 Burden on Adult Cardiac Surgery Case Volumes {#sec2.3}
---------------------------------------------------------------

Hospital case volumes for adult cardiac surgery declined to 60% of baseline in March 2020 and then to 45% of baseline in April 2020 (for all institutions combined---baseline 5354 vs March 3061 vs April 2356 cases per month), with national and regional variations. The decline was greatest in adult cardiac surgery case volumes corresponding to baseline activity, in the Northeast region of the United States in April 2020 (United States: Northeast 36% of baseline \[10%-69%\], Southeast 50% of baseline \[25%-84%\], Southwest 37% of baseline \[8%-82%\], Midwest 39% of baseline \[20%-70%\], West 46% of baseline \[21%-73%\]; Canada: Eastern 51% of baseline \[12%-94%\], Western 62% of baseline \[35%-90%\]) ([Figure 2](#fig2){ref-type="fig"} , *A*). Institutions with high COVID-19 burden experienced a greater decline in operative volume from baseline in April 2020, which was not significant (high burden 40% of baseline \[12%-70%\] vs low burden 48% of baseline \[8%-90%\]) ([Figure 2](#fig2){ref-type="fig"}, *B*).Figure 2A, Effect of COVID-19 on adult cardiac surgery case volume stratified by North American regions; and B, high and low COVID-19 hospitalization burden. High COVID-19 burden was defined as institutions with \>100 hospitalization patients with confirmed or suspected COVID-19. *COVID-19*, Coronavirus disease 2019.

Effect of COVID-19 on Adult Cardiac Surgery Case Mix {#sec2.4}
----------------------------------------------------

Cardiac surgery case mix pre-COVID-19 as compared with during COVID-19 is shown in [Figure 3](#fig3){ref-type="fig"} , *A*. An overall increase in the proportion of coronary artery bypass grafting (CABG) surgeries performed during COVID-19 (during 47% vs pre 41%) was observed, with a corresponding decline in valvular cases, with isolated valve surgery (during 23% vs pre 27%) and CABG combined with valve surgery (during 8% vs pre 12%). Institutions with high COVID-19 burden had nonsignificant trends toward a greater proportion of operative cases as CABG (high burden +7.2% vs low burden +4.2%, *P* = .550), extracorporeal membrane oxygenation (ECMO) (high burden +2.5% vs low burden 0.4%, *P* = .328), and heart transplantation (high burden +2.7% vs low burden 0.4%, *P* = .090), probably due to the fact that those are usually urgent or emergent, with a nonsignificant lower proportion of valvular cases (high burden --7.6% vs low burden --2.6%, *P* = .195) and aortic surgery (high burden --3.5% vs low burden --1.0%, *P* = .328), although the overall number of cardiac surgical case volume during COVID-19 was significantly declined compared with baseline ([Figure 3](#fig3){ref-type="fig"}, *B*, and [Figure 4](#fig4){ref-type="fig"} ).Figure 3A, Effect of COVID-19 on cardiac surgery case mix pre- versus during the COVID-19 pandemic and; B, change in case mix when stratified by high and low COVID-19 hospitalization burden. *COVID-19*, Coronavirus disease 2019; *ECMO*, extracorporeal membrane oxygenation; *MCS*, mechanical circulatory support; *CABG*, coronary artery bypass grafting.Figure 4The decline in cardiac surgery case volume in North America during the COVID-19 pandemic and change in cardiac surgery case mix. *COVID-19*, Coronavirus disease 2019; *ECMO*, extracorporeal membrane oxygenation; *MCS*, mechanical circulatory support; *CABG*, coronary artery bypass grafting.

Preoperative Testing Practices for COVID-19 {#sec2.5}
-------------------------------------------

The majority of institutions required COVID-19 testing of all cardiac surgical patients preoperatively for COVID-19 (n = 40, 60%), with a minority requiring COVID-19 testing of all cardiac surgical emergency patients for COVID-19 as well (n = 27, 40%), with national and regional variations reflective of COVID-19 level of burden ([Table 2](#tbl2){ref-type="table"}).

Modality of Follow-up for Cardiac Surgical Patients {#sec2.6}
---------------------------------------------------

Recognizing the potential deleterious impact of delayed cardiac surgical operations to conserve hospital resources and personnel for the treatment of patients with COVID-19, the majority of institutions have some mechanism of allowing preoperative cardiac surgical patients to seek expert opinion without the need to venture into the emergency department (82%). Of those institutions with this mechanism for patients to seek help, the majority of modalities were follow-up as needed by providing patients with a contact number to reach out to if there are any concerns (85%), whereas some institutions proactively reached out to deferred patients every 1 to 2 weeks to monitor a patient\'s cardiovascular symptoms (15%) ([Table 2](#tbl2){ref-type="table"}). National and regional variations existed in allowing a mechanism for preoperative cardiac surgical patients to seek care without going to the emergency department, with fewer institutions in the Northeastern United States (60%) and Eastern Canada (78%) having such mechanisms in place. Importantly, these were associated with cardiac surgeon regional differences in the use of telemedicine, with telemedicine used in only 27% of institutions in the Northeastern United States and 22% of institutions in Eastern Canada ([Table 2](#tbl2){ref-type="table"}). This is further corroborated by institutions with high COVID-19 burden being less likely to use telemedicine than those with low COVID-19 burden (high 77% vs low 98%, *P* = .012) ([Table 3](#tbl3){ref-type="table"}).

Outcomes of Patients With COVID-19 Who Underwent Cardiac Surgical Operations {#sec2.7}
----------------------------------------------------------------------------

Among all institutions combined, there were a total of 9820 patients hospitalized with confirmed COVID-19 and 4820 with suspected COVID-19 identified at the reporting centers. Thirteen patients with known COVID-19 infection underwent cardiac surgical operations, with 1 (8%) death. A total of 65 patients with suspected COVID-19 underwent cardiac surgical operations, with 5 (8%) mortalities. Cumulatively, there were 131 patients (1% of all patients with COVID-19 hospitalized) who were reported to require ECMO for cardiorespiratory failure, of whom 24 (18%) died, and others either remained on ECMO at time of survey or survived.

Discussion {#sec3}
==========

With more than 4 million cases worldwide at the time of publication, the COVID-19 pandemic presents a public health crisis that challenges the availability of health care personnel and resources.[@bib12] The impact of COVID-19 has been felt differently across the cardiovascular community at the national and regional levels due in part to differences in prevalence of infection rates and the social and health care system response.[@bib14]

In this comprehensive survey report of the effect of COVID-19 on cardiac surgical institutions in North America with diverse geographic distribution, we demonstrate that cardiac surgical case volumes have declined to 45% of baseline following COVID-19 with national and regional variation. Interestingly, the trend of decline in the number of cases was of the same for institutions that were in high COVID-19 burden areas compared with those in low-burden areas, indicating a consistent response from institutions in the preparation or confrontation with COVID-19. Institutions with high COVID-19 burden had significant decline in total case volume, with change in case mix, that did not meet statistical significance, largely providing urgent or emergent care for procedures, such as CABG, ECMO, and heart transplantations, rather than valvular and aortic surgical cases.

Operative outcomes of patients with COVID-19 undergoing a cardiac surgical procedure remains unknown. Pooling the collective experience of 67 North American centers in this study, we demonstrate that overall, unadjusted mortality rates for patients with confirmed or suspected COVID-19 who underwent cardiac surgical operations was 8%. Furthermore, we report the combined North American experience of outcomes of ECMO in the management of COVID-19 was associated with greater survival than some previous reports (n = 131, of which 82% still alive either decannulated or still supported). These results compare favorably with those previously reported in a systematic review and meta-analysis of patients with COVID-19 who underwent ECMO (n = 17, of which 6% survived)[@bib15] and the COVID-19 ECMO registry through the Extracorporeal Life Support Organization (n = 264, of which 124 were discharged alive \[46%\]),[@bib16] although we are unable to elucidate any further outcomes beyond survival alone.

In efforts to preserve or redirect limited resources and personnel for the treatment of patients with COVID-19, most nonurgent cardiac surgical services were deferred in a fashion that was consistent with recent Taskforce and Society guidance statements.[@bib1] ^,^ [@bib4] This was consistent in the majority of cardiac surgical institutions reporting either high or low burdens of hospitalized patients with COVID-19, although regional variations did exist. Our findings of changes in cardiac surgical case mix to prioritize more urgent cases such as CABG and ECMO with COVID-19 contextualize ongoing recommendations on selection and triage of cardiac surgeries[@bib1] ^,^ [@bib4] in the increasingly challenging health care situation caused by the COVID-19 pandemic.

The implications of deferred cardiac surgical operations remain unknown, however, previous studies examining deferral of cardiac surgical operations due to limited capacity has been associated with an increase in operative mortality for patients on the waiting list.[@bib17], [@bib18], [@bib19] The current analysis is important, given the poor outcomes with the natural history of cardiac surgical disease, such as severe aortic stenosis with reported mortality rates while awaiting surgical treatment to be as high as 3.7% at 1 month and 11.6% at 6 months,[@bib19] whereas for patients awaiting CABG, median waiting list mortality rates can be as high as 2.6% to 11.0% per month.[@bib17]

Another emerging concern of the cardiovascular community is patient reluctance to seek care at a hospital during the COVID-19 outbreak, which has been inferred from the recent 40% reduction in patients presenting to hospital with an ST-elevation myocardial infarction (STEMI) during the COVID-19 crisis.[@bib20] Other potential reasons for reduced STEMI presentations could relate to altered patient behavior or psychological responses to STEMI symptoms, disrupted care pathways, or altered cardiovascular risk factors pertaining to lockdown conditions during the pandemic.[@bib20] It remains to be seen if a collateral effect of COVID-19 surge planning that has resulted in an increased number of patients being deferred will result in greater rates of perioperative morbidity and mortality. Discussions in different surgical forums already share the resurgence of conditions due to delayed presentations for cardiac surgery including, but not limited to, mechanical complications of myocardial infarction such as acute ventricular septal defect.

There is a need for intensified triage, patient counseling, empowerment, and proactive follow-up,[@bib21] with the provision of virtual emergency care triage for cardiovascular patients,[@bib22] to allow for timely evaluation without subjecting patients to unnecessary travel to the emergency department. Ultimately, with reduced access to diagnostic testing and operations, there is a concern of a surge of patients with cardiovascular disease who will require treatment. Institutions should plan for future transitions during pandemics into safe zones to allow vital services to operate with minimized disruptions to maintain the standard of care in the diagnosis and management of cardiovascular diseases---which remains a major cause of annual mortality in North America, with more than 900,000 patients deaths per year.[@bib3]

Unprecedented times call for unprecedented collaboration.[@bib23] There is a need for real-time sharing of expertise and experiences[@bib2] ^,^ [@bib24] and to be proactive, and contribute our skill sets, both within and outside our traditional scopes of practice where necessary.[@bib4] ^,^ [@bib25] Our study provides unique information on cardiac surgical patients that can be generalized to other health conditions to assist health care policymakers and institutions in their need to not only consider methods for containing and treating these infections, but also how infection outbreaks may affect systems of care beyond the immediate infection. Furthermore, as the COVID-19 pandemic abates, appropriate strategies and system-wide adjustments are needed to increase cardiac surgical operating capacity to reduce substantial delays and increased cardiovascular patient morbidity and mortality on the waiting list---estimates include the need to perform 263% of monthly baseline volume to clear the backlog of cases in 1 month.[@bib11]

Limitations {#sec3.1}
-----------

Our study is subject to response bias and relies on center self-reported data. The response rate to this survey was 40%; however, the sites included represent a diverse geographic sample and a significant annual case volume. We were not made aware of specific institutional triage strategies, composition of the waiting list, and decision-making of each institution when prioritizing surgeries. Due to the small number of patients with COVID-19 who underwent cardiac surgeries or ECMO, we were unable to adjust for comorbidities, complications from COVID-19, stratify venoarterial versus venovenous ECMO, or describe other outcomes of these patients other than mortality at the time of the survey. We do not have data in regard to the number of patients who were referred for transcatheter aortic valve replacement instead of surgical aortic valve replacement for the purposes of reducing postoperative length of stay and perioperative risks. Our study is a snapshot of a rapidly evolving situation affecting heterogenous populations and regions with variable testing and responses due to the pandemic\'s impact. Participating institutions were predominantly from academic institutions and may not reflect that of community programs. Furthermore, institutions with fewer hospital beds may be proportionally more greatly affected due to limited resources, although this remains to be determined. Given the resource intensive nature of cardiac surgery and demonstrated feasibility of enhanced recovery after cardiac surgery programs[@bib26] and minimally invasive techniques[@bib27] in reducing postoperative intensive care length of stay, the utility of fast-track postoperative pathways can be a promising avenue for investigation. In addition, these pathways can potentially be further refined to conserve essential hospital resources in the COVID-19 era while maintaining the safety of our patients.

Conclusions {#sec4}
===========

We describe the first comprehensive survey report of North American adult cardiac surgical experience with COVID-19 and demonstrate national and regional variations in response to COVID-19. The COVID-19 pandemic has resulted in a decline to 45% of baseline cardiac surgery case volumes as most institutions defer nonurgent operations, with changes in case mix. These findings can inform institutions and health care systems regarding the regional and national impact of the pandemic on hospital case volume and mix. The data also provide valuable information regarding the volume of patients with their procedures deferred to help government and institutions predict and prepare for the post--COVID-19 surge in cardiac surgery demand.
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[^1]: *ICU*, Intensive care unit; *COVID-19*, coronavirus disease 2019; *CABG*, coronary artery bypass grafting surgery; *ECMO*, extracorporeal membrane oxygenation; *MCS*, mechanical circulatory support.

[^2]: *COVID-19*, Coronavirus disease 2019; *CSICU*, cardiac surgery intensive care unit; *CCU*, cardiovascular care unit; *ED*, emergency department.

[^3]: *ICU*, Intensive care unit; *COVID-19*, coronavirus disease 2019; *CABG*, coronary artery bypass grafting surgery; *ECMO*, extracorporeal membrane oxygenation; *MCS*, mechanical circulatory support; *CSICU*, cardiac surgery intensive care unit; *CCU*, cardiovascular care unit; *ED*, emergency department.
